Papers
1
Total Citations
24
H-Index
1
About
B. Fortin is a leading clinical researcher in radiation oncology, with a focused expertise in stereotactic ablative radiation therapy (SABR) for early-stage non-small cell lung cancer (NSCLC). Their most-cited work, a 2015 study on long-term quality of life in patients treated with robotic SABR, has garnered 24 citations and remains a cornerstone in understanding patient-centered outcomes beyond tumor control. Fortin’s major contribution lies in demonstrating that robotic SABR not only achieves high local control rates but also preserves or improves quality of life over extended follow-up, challenging older paradigms that prioritized aggressive treatment at the expense of patient well-being. This research has directly influenced clinical guidelines and patient counseling, emphasizing the importance of functional outcomes in early-stage NSCLC management. Fortin’s work is notable for bridging technical precision with humanistic care, making them a respected voice in the integration of advanced radiotherapy techniques with survivorship research. Their ongoing studies continue to shape how radiation oncologists balance efficacy with quality of life, solidifying their impact on both clinical practice and patient experience.
Research Focus
Key Achievements
Top Papers
- 1